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Background: Time to reperfusion therapy and outcomes among patients who develop ST-elevation myocardial infarction (STEMI) during 
hospitalization have not been reported.
Methods: From 12/2007 to 3/2009, 30 patients developed STEMI during hospitalization at Saint Marys Hospital. We compared patient 
characteristics, time metrics from electrocardiogram (ECG) to primary percutaneous coronary intervention (PCI), and inhospital mortality for patients 
(n=30) who develop STEMI during hospitalization versus patients (n=412) who presented to the emergency department (ED) with STEMI.
Results: Patients who develop STEMI during hospitalization were older and had more comorbidities with a higher likelihood of: hypertension (87% 
versus 59%), diabetes (30% versus 18%) and coronary artery disease (53% versus 28%). Median times from ECG to PCI were 135 versus 58 minutes 
(p<0.001) for patients who developed STEMI during hospitalization and patients who presented with STEMI to the ED. The largest component of 
delay was the median time from ECG acquisition to catheterization lab activation 58 versus 5 minutes (p<0.001) for the respective groups. Patients 
who develop STEMI during the hospitalization had a higher risk of inhospital death (20% versus 7% p=.016).
Table 1. 
Time Interval
ED STEMI
(n=412)
In-Hospital STEMI
(n=30)
P
ECG to Cath Lab Activation 5.0 (2.0, 13.0) 58.0 (25.0, 111.0) <0.001
ECG to Lidocaine Administered 39.0 (31.0, 50.0) 92.5 (61.1, 151.6) <0.001
ECG to PCI 58.0 (47.0, 75.0) 135.0 (90.0, 196.0) <0.001
Cath Lab Activation to Lidocaine 
Administered
31.0 (25.0, 37.0) 38.1 (33.0, 42.4) 0.003
Lidocaine Administered to PCI 16.0 (13.0, 24.0) 20.2 (14.0, 31.5) 0.242
Conclusions: Patients who develop STEMI during hospitalization represent a vulnerable patient subgroup with delays in time to primary PCI and 
higher in-hospital mortality.
